Pfizer settles the long-running federal Genotropin probe. This case has ties to Peter Rost, who wrote the book “The Whistleblower” about his dealings with Pfizer regarding this incident.
Merck scores again with Januvia/metformin combo (Janumet).
Takeda’s Actos for diabetes may slow the thickening of artery walls.
Abbott gets approval for coated (time-released) Niaspan.
Another (early-stage) interesting molecule for fighting cholesterol.
J&J/Tibotec’s new AIDS treatment, Prezista, looking very promising.
The “new” Bayer (after merger with Berlex) is officially launched – Bayer Healthcare Pharmaceuticals. They will add jobs in NJ.